⌘K

Login Start Free

Home/Insiders/Mahatme Ujwala

MU

SEC Insider//CIK 0001823894

Mahatme Ujwala

CIK 00018238941 companyCAMBRIDGE, MA

Transactions

7

Companies

1

Filings

4

CIK

0001823894

Recent Transactions

7 trades

Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2024-01-02+35,000→ 35,000 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2024-01-02$1.32/sh+52,575→ 87,575 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2023-01-03+35,000→ 35,000 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2023-01-03$1.67/sh+40,500→ 75,500 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2022-01-03+25,000→ 25,000 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2022-01-03$1.13/sh+47,872→ 72,872 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2021-02-19+25,000→ 238,340 total

Companies

1

Summit Therapeutics Inc.
Director
$SMMT

Recent Filings

4

Address

C/O SUMMIT THERAPEUTICS INC., ONE BROADWAY, 14TH FLOOR

CAMBRIDGE, MA, 02142

View on SEC.gov